Author:
Kishikawa Hiroshi,Nishida Jiro,Inokuchi Sayaka,Kaida Shogo,Morishita Tetsuo,Hibi Toshifumi
Publisher
The Japanese Society of Strategies for Cancer Research and Therapy
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference12 articles.
1. 1) The Editorial Board of the Cancer Statistics in Japan. Cancer Statistics in Japan 2005. Tokyo: Foundation for Promotion of Cancer research.
2. 2) Burris, HA 3rd., Moore, MJ., Anderson, J., Green, MR., Rothenberg, ML., Modiano, MR., Cripps, MC., Portenoy, RK., Storniolo, AM., Tarassoff, P., Nelson, R., Dorr, FA., Stephens, CD., and Von Hoff, DD. (1997) Improvements in survival and clinical benefit with gemcitabine as first therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 15: 2403-2413.
3. Reporting results of cancer treatment
4. 4) Muhammad, Wasif Saif. (2007) Pancreatic cancer: Are we moving forward yet? Highlights from the gastrointestinal cancers symposium. Orland, FL, USA. January 20th, 2007. J Pancreas. 8: 166-176.
5. 5) Okada, S., Ueno, H., Okusaka, T., Ikeda, M., Furuse, J., and Maru, Y. (2001) Phase I trial of gemcitabine in patients with advanced pancreatic cancer. Jpn J Clin Oncol. 31: 7-12.